A nationwide cohort study conducted in Finland has found that risk of clozapine‐induced agranulocytosis, while greater than that associated with other antipsychotics, decreases considerably with longer‐term use of the medication. The study's findings lend support to the idea that hematological monitoring requirements for patients receiving clozapine could be relaxed over time, the investigators stated. Study results were published online April 29, 2024, in Lancet Psychiatry .
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: